Similar Posts
This Simple TFSA Plan Could Pay You Monthly in 2026
You don’t have to be a genius to earn monthly passive income from your Tax-Free Savings Account (TFSA). A simple investment plan is sufficient. Source: Getty Images A simple TFSA plan for 2026 Identify investments that have consistently delivered passive income and continue to do so. Consider scenarios that could put income at risk, and…
Here Are My Top 3 TSX Stocks to Buy Right Now
The current market environment requires a deliberate approach to investing. Expect extreme volatility to persist as long as the war rages. Until then, the goal is to build a fortress-like foundation in 2026. If you want a portfolio that can withstand market shocks, Royal Bank of Canada (TSX:RY), Canadian National Railway (TSX:CNR), and Alimentation Couche-Tard…
AutoZone Pulling Back Into the Buy Zone
Key Points AutoZone had a solid quarter, but results are mixed relative to consensus, and shares are pulling back. The uptrend is intact and will likely result in a buy-signal soon. Cash flow and massive share buybacks support the uptrend and point to a new all-time high before year-end. 5 stocks we like better than…
November Vehicle Sales Forecast: 16.2 million SAAR, Up 5% YoY
by Calculated Risk on 11/22/2024 05:18:00 PM From WardsAuto: November U.S. Light-Vehicle Sales to Improve on October’s Growth (pay content). Brief excerpt: November’s forecast SAAR of 16.2 million units is the highest since May 2021. With the month having an atypical fifth weekend, the extended timeframe means there is more upside than downside to November’s…
Guide to Advanced Tokenomics for Blockchain Ecosystems
Lesson Objectives By the end of this lesson, learners will be able to: Understand the key classifications of tokens and their roles in blockchain ecosystems. Analyze various token supply models, including fixed, inflationary, elastic, and dual-token systems. Explore incentive mechanisms such as staking, liquidity mining, and token burnsToken burning refers to the process of permanently…
Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY
Glenmark Pharma on Wednesday reported a net loss of Rs 121 crore in the fourth quarter ended March 31, 2024, due to declining sales in the US and exceptional items. The drugmaker reported a net loss of Rs 34.5 crore in the corresponding quarter of the previous year. Revenue was at Rs. 3063 crore as…
